This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
by Indrajit Bandyopadhyay
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
SYKPositive Net Change ISRGPositive Net Change GMEDPositive Net Change
medical medical-devices
New Strong Sell Stocks for Oct. 14th
by Zacks Equity Research
AR, BTCS and ATOS have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2025.
ATOSNegative Net Change ARNegative Net Change BTCSPositive Net Change
finance medical-devices oil-energy
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
by Zacks Equity Research
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
BDXPositive Net Change RMDNegative Net Change MASINegative Net Change SOLVPositive Net Change
medical medical-devices
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
by Zacks Equity Research
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change INSPPositive Net Change
medical medical-devices
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
by Moumi Mondal
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
UNHNegative Net Change HUMPositive Net Change CVSPositive Net Change
medical medical-devices
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
by Zacks Equity Research
PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.
EWPositive Net Change MASINegative Net Change PLSENegative Net Change NDRANegative Net Change
medical medical-devices
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
by Zacks Equity Research
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
BDXPositive Net Change RMDNegative Net Change MASINegative Net Change SOLVPositive Net Change
medical medical-devices
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
by Urmimala Biswas
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
LHPositive Net Change CRLPositive Net Change TDOCNegative Net Change
hospitals medical medical-devices smart-health
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
by Zacks Equity Research
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change PACBNegative Net Change
medical medical-devices
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
by Zacks Equity Research
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change GEHCPositive Net Change
medical medical-devices
FuelCell Energy (FCEL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
FCELNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
A-Mark Precious Metals (AMRK) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AMRKNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Grab These 4 Stocks With Solid Net Profit Margin to Maximize Returns
by Anirudha Bhagat
Let's take a look at four stocks, AVO, ELMD, GLDD and CENX, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
ELMDNegative Net Change GLDDNegative Net Change CENXNegative Net Change AVONo Net Change
agriculture industrial-products medical medical-devices transportation
Ecolab Brings Direct-to-Chip Cooling Monitoring to Southeast Asia
by Zacks Equity Research
ECL debuts its 3D TRASAR direct-to-chip cooling monitoring in Singapore, boosting efficiency and sustainability in data centers.
ECLPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
by Zacks Equity Research
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
OMIPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs
by Zacks Equity Research
NEOG's Q1 earnings decline 42.9% year over year, while revenues of $209.2 million top the consensus mark.
BSXPositive Net Change NEOGNegative Net Change PODDPositive Net Change PAHCPositive Net Change
earnings medical medical-devices
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
by Zacks Equity Research
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change ZBHPositive Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Ardent Health Stock?
by Zacks Equity Research
Investors need to pay close attention to Ardent Health stock based on the movements in the options market lately.
ARDTPositive Net Change
medical medical-devices
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
by Zacks Equity Research
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
ISRGPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
Hims & Hers Expands Personalized Care Access Via Telehealth Platform
by Debanjana Dey
HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.
GDRXNegative Net Change HIMSNegative Net Change LFMDNegative Net Change
medical medical-devices
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
by Zacks Equity Research
Revvity partners with Sanofi to launch a scalable diagnostic test for early T1D detection, expanding its reach beyond rare diseases.
SNYPositive Net Change MASINegative Net Change MMSIPositive Net Change RVTYNegative Net Change
medical medical-devices
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
by Moumi Mondal
CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.
HUMPositive Net Change CVSPositive Net Change CNCNegative Net Change
medical medical-devices
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
ECLPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
by Zacks Equity Research
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
RMDNegative Net Change MASINegative Net Change PACBNegative Net Change SOLVPositive Net Change
medical medical-devices
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
by Zacks Equity Research
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
CAHPositive Net Change MCKPositive Net Change CORPositive Net Change
medical medical-devices